Mizuho Securities Sticks to Its Buy Rating for Cabaletta Bio (CABA)
August 11 2022 - 08:15PM
TipRanks
In a report released yesterday, Uy Ear from Mizuho Securities
reiterated a Buy rating on Cabaletta Bio (CABA - Research Report),
with a price target of $10.00. The company's shares closed
yesterday at $1.45.According to TipRanks, Ear is a 4-star analyst
with an average return of 15.5% and a 66.67% success rate. Ear
covers the Healthcare sector, focusing on stocks such as Arcutis
Biotherapeutics, ACADIA Pharmaceuticals, and uniQure.Currently, the
analyst consensus on Cabaletta Bio is a Moderate Buy with an
average price target of $10.50.
https://www.tipranks.com/news/blurbs/mizuho-securities-sticks-to-its-buy-rating-for-cabaletta-bio-caba-2?utm_source=advfn.com&utm_medium=referral
Cabaletta Bio (NASDAQ:CABA)
Historical Stock Chart
From Dec 2022 to Jan 2023
Cabaletta Bio (NASDAQ:CABA)
Historical Stock Chart
From Jan 2022 to Jan 2023